Back to Trials
NCT05820672Recruiting

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

Ascendis Pharma Endocrinology Division A/S

Start Date

3/20/2023

Completion Date

3/1/2033

Summary

The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care

Detailed Description

Patients will be treated according to routine clinical practice, and no additional visits, examinations or tests will be required beyond those performed as part of routine clinical practice except for COAs.

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria: * Patients who are on treatment with SKYTROFA (lonapegsomatropin) * Patients being clinically managed in USA * Patients with an appropriate written informed consent/assent as applicable for the age of the patient Exclusion Criteria: * Patients participating in any interventional clinical study

Interventions

OTHER

No intervention

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Growth Hormone Deficiency

Locations

Ascendis Investigational Site

Phoenix, Arizona 85054

United States

Ascendis Investigational Site

Orange, California 92868

United States

Ascendis Investigational Site

Sacramento, California 95821

United States

Ascendis Investigational Site

San Francisco, California 94143

United States

Ascendis Pharma Investigational Site

Centennial, Colorado 80112

United States

Ascendis Investigational Site

Washington D.C., District of Columbia 20010

United States

Ascendis Investigational Site

Orlando, Florida 32806

United States

Ascendis Investigational Site

Orlando, Florida 32827

United States

Ascendis Investigational Site

Tampa, Florida 33612

United States

Ascendis Investigational Site

Sandy Springs, Georgia 30350

United States

Ascendis Investigational Site

Boise, Idaho 83712

United States

Ascendis Investigational Site

Indianapolis, Indiana 46202

United States

Ascendis Investigational Site

Iowa City, Iowa 52242

United States

Ascendis Investigational Site

Louisville, Kentucky 40202

United States

Ascendis Investigational Site

Minneapolis, Minnesota 55455

United States

Ascendis Investigational Site

Las Vegas, Nevada 89113

United States

Ascendis Investigational Site

Lebanon, New Hampshire 03756

United States

Ascendis Investigational Site

Manchester, New Hampshire 03104

United States

Ascendis Investigational Site

Morristown, New Jersey 07960

United States

Ascendis Investigational Site

New Hyde Park, New York 11042

United States

Ascendis Investigational Site

Cincinnati, Ohio 45229

United States

Ascendis Investigational Site

Portland, Oregon 97239

United States

Ascendis Investigational Site

Columbia, South Carolina 29203

United States

Ascendis Investigational Site

Dallas, Texas 75390

United States

Ascendis Investigational Site

El Paso, Texas 79907

United States

Ascendis Investigational Site

Norfolk, Virginia 23507

United States

Ascendis Investigational Site

Seattle, Washington 98105

United States